Dr Marwah Upcoming Classes 2025
Prepare complete syllabus of Medicine for entrance exams like NEET PG, INICET, FMGE etc. with Dr. Deepak Marwah.
Dr Marwah Publications
Prepare complete syllabus of Medicine with Dr Marwah Books for entrance exams like NEET PG, INICET, FMGE etc. with Dr. Deepak Marwah.
Dr. Deepak Marwah is an academician and clinician, who has been teaching young, budding doctors for post graduate entrance exams for over 15 years. He is an alumnus from the Maulana Azad Medical College, New Delhi.
His classes give an interesting insight into the fascinating world of diagnostic and therapeutic science. He loves to reverse engineer the current clinical profile of patients to teach the pathophysiology of disease in an integrated matter, which is the need of the current pattern of examination in India.
Our Students' Success Stories
Nothing is more rewarding to a teacher than the success of his students. We are proud of each one of you.
Free Video Lectures
Nothing is more rewarding to a teacher than the success of his students. We are proud of each one of you.
Guidance Center
During my experience as an academician and clinician I have leart a few lessons and this where I share those with you, my dear students. Hope you find them useful.
A PCSK9 Inhibitor in a Tablet? Meet Enlicitide, the New Oral Cholesterol Drug
For years, there was an easy examination question: “What is the major disadvantage of PCSK9 inhibitors?” One obvious answer was: they are injectable. Not anymore. On July 17, 2026, the US FDA approved enlicitide, marketed as Lipfendra, making it the first FDA-approved oral PCSK9 inhibitor for lowering LDL cholesterol in adults with hypercholesterolemia, including heterozygous familial hypercholesterolemia […]
FDA Approves First Oral Drug for Dermatomyositis
Brepocitinib (Lisraya) Explained: Mechanism, VALOR Trial, Dose, Safety & Exam Pearls By Dr Deepak Marwah | Marwah Medicine A major change has arrived in dermatomyositis treatment. On August 27, 2026, the US FDA approved brepocitinib (Lisraya) tablets for adults with dermatomyositis, making it the first FDA-approved oral treatment specifically indicated for adult dermatomyositis. HIGH-YIELD ONE-LINER Brepocitinib = […]